Clinical Trials Browser

OTHER × Neuroblastoma × lestaurtinib × Clear all

NCT00084422 2023-04-10

N2001-03: CEP-701 in Treating Young Patients With Recurrent or Refractory High-Risk Neuroblastoma

Phase 1 Completed

Neuroblastoma